Genetic Variation in VP7 Gene of Human Rotavirus Serotype 2 (G2 Type) Isolated in Japan, China, and Pakistan

Sequence analysis of the gene encoding the major neutralization glycoprotein (VP7) was performed on sixteen human isolates of serotype 2 of rotavirus in Japan, China, and Pakistan and their genetic variations were examined. Comparative studies of their nucleotide and deduced amino acid sequences between the sixteen isolates and the HU5 strain revealed an overall homology of more than 94%. A higher degree of homology in nucleotides was observed among the sixteen isolates than between HU5 and the isolates. A total of thirteen amino acid residues frequently converted to another amino acid. Out of the thirteen, five amino acid residues belonging to the major neutralizing epitope regions (C, E, and F in this communication) converted frequently. From the amino acid sequences three subtypes, subtype 1, subtype 2, and intermediate, were suggested to be classified as previously reported for serotype 1 (Xin et al, Virology, 1993, 197: 813‐816).

[1]  R. Glass,et al.  Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children , 1995 .

[2]  H. Ushijima,et al.  Genetic variation in VP7 gene of human rotavirus serotype 1 (G1 type) isolated in Japan and China. , 1993, Virology.

[3]  H. Ushijima,et al.  Detection and serotyping of rotaviruses in stool specimens by using reverse transcription and polymerase chain reaction amplification , 1992, Journal of medical virology.

[4]  R. Glass,et al.  Identification of group A rotavirus gene 4 types by polymerase chain reaction , 1992, Journal of clinical microbiology.

[5]  G. Gerna,et al.  Genetic variation in rotavirus serotype 4 subtypes. , 1992, Virology.

[6]  B. Coulson,et al.  Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype , 1991, Journal of virology.

[7]  G. Browning,et al.  A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23 , 1991, Journal of clinical microbiology.

[8]  R. Glass,et al.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens , 1990, Journal of clinical microbiology.

[9]  G. Gerna,et al.  Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies , 1988, Journal of clinical microbiology.

[10]  R. Chanock,et al.  Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. , 1987, Virology.

[11]  A. Kapikian,et al.  PROTECTION AGAINST SEVERE ROTAVIRUS DIARRHOEA BY RHESUS ROTAVIRUS VACCINE IN VENEZUELAN INFANTS , 1987, The Lancet.

[12]  Protection against severe rotavirus diarrhea by rhesus rotavirus vaccine , 1987 .

[13]  G. Zissis,et al.  FAILURE OF LIVE, ATTENUATED ORAL ROTAVIRUS VACCINE , 1986, The Lancet.

[14]  G. Gerna,et al.  Characterization of serotypes of human rotavirus strains by solid-phase immune electron microscopy. , 1985, The Journal of infectious diseases.

[15]  R. Glass,et al.  Nucleotide sequence of the structural glycoprotein VP7 gene of Nebraska calf diarrhea virus rotavirus: comparison with homologous genes from four strains of human and animal rotaviruses. , 1985, Virology.

[16]  A. Kapikian,et al.  Isolation of human rotavirus subgroups 1 and 2 in cell culture , 1982, Journal of clinical microbiology.

[17]  T. Konno,et al.  Two Distinct Electrophoretic Migration Patterns of RNA Segments of Human Rotaviruses Prevalent in Japan in Relation to Their Serotypes , 1982, Microbiology and immunology.